Cabozantinib-Induced Severe Cardiac Dysfunction: A Case Report and a Systematic Review of the Literature

Cabozantinib is a novel multitargeted receptor tyrosine kinase inhibitor commonly used to treat advanced renal cell carcinoma. Cardiotoxicity is not a previously well-described adverse effect of cabozantinib. We present a rare case of a 74-year-old male with a history of renal cell carcinoma who und...

Descripción completa

Detalles Bibliográficos
Autores principales: Buttar, Chandan, Lakhdar, Sofia, Nassar, Mahmoud, Landry, Ian, Munira, Most
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057634/
https://www.ncbi.nlm.nih.gov/pubmed/35509750
http://dx.doi.org/10.7759/cureus.23740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057634/
https://www.ncbi.nlm.nih.gov/pubmed/35509750
http://dx.doi.org/10.7759/cureus.23740

Ejemplares similares